Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04486170 · ClinicalTrials.gov registry record · NA

Assessment of Postpartum Education to Improve Compliance

A NA study, sponsored by Medstar Health Research Institute.

Completed
Registry status
NA
Development phase
46
Enrollment target

NCT04486170: Completed NA study, sponsored by Medstar Health Research Institute.

NCT04486170 is a NA study that has completed, run by Medstar Health Research Institute. The registered enrollment target is 46 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04486170, a NA study, has completed, sponsored by Medstar Health Research Institute.

COMPLETED
Registry status
NA
Development phase
46 participants
Enrollment target

Study Summary

This is a prospective single centered randomized control study for postpartum patients diagnosed with hypertension. Participants that meet inclusion criteria will be approached while they are inpatient. After enrollment, all study subjects will receive an automated blood pressure cuff and instructions on how to use it. Study participants in the intervention group will be provided with educational material. The investigators hypothesize education in postpartum women with hypertension can improve patient compliance with attendance at postpartum care appointments.

Primary Outcome

The investigators will perform a retrospective chart review to determine if the study participant attended the postpartum BP check appointment

Interventions

  • OTHER Education provided via a video format

Trial Details

FieldValue
Enrollment Target 46 participants
Start Date 2020-09-14
Est. Completion 2021-12-15
Phase NA
Medstar Health Research Institute

115 total trials

What the finished NCT04486170 record still lists

NCT04486170 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 46 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 1 intervention - of which Education provided via a video format is the first listed.

NCT04486170 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04486170 about?

NCT04486170 is a clinical study titled "Assessment of Postpartum Education to Improve Compliance". This is a prospective single centered randomized control study for postpartum patients diagnosed with hypertension. Participants that meet inclusion criteria will be approached while they are inpatient. After enrollment, all study subjects will receive an automated blood pressure cuff and instructio...

What is the current status of trial NCT04486170?

This trial is currently completed. It is a NA study. The enrollment target is 46 participants. The study started on 2020-09-14. Estimated completion is 2021-12-15.

What interventions are being tested in trial NCT04486170?

The interventions under investigation include: Education provided via a video format (OTHER).

Who is sponsoring clinical trial NCT04486170?

This trial is sponsored by Medstar Health Research Institute, which has 115 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04486170's enrollment target sits among peer trials

46 1402nd of 2000 higher than 590 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01890590 · 46 participants · NA

    A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma

  • NCT03191149 · 46 participants · Phase 2

    Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

  • NCT03510208 · 46 participants · Phase 1

    Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery

  • NCT04048278 · 46 participants · Early Phase 1

    Lidocaine Infusion in Pancreatic Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04486170, the US trial registry maintained by the National Library of Medicine. NCT04486170 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.